Tenax Therapeutics, Inc. (TENX)

1.94 +0.16 (+8.99%) USD  |  NASDAQ  |  Sep 04, 16:00
1.92 -0.02 (-1.03%) Pre-Market: 20:00
More

Tenax Therapeutics SG&A Expense (TTM) : 23.36M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for TENX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 23.36M
March 31, 2026 23.09M
December 31, 2025 23.71M
September 30, 2025 20.51M
June 30, 2025 15.53M
March 31, 2025 11.21M
December 31, 2024 6.785M
September 30, 2024 5.726M
June 30, 2024 5.270M
March 31, 2024 4.964M
December 31, 2023 5.005M
September 30, 2023 4.783M
June 30, 2023 5.109M
March 31, 2023 5.408M
December 31, 2022 5.675M
September 30, 2022 6.552M
June 30, 2022 7.814M
March 31, 2022 7.748M
December 31, 2021 7.581M
September 30, 2021 7.227M
June 30, 2021 5.760M
March 31, 2021 5.358M
December 31, 2020 5.307M
September 30, 2020 4.756M
June 30, 2020 4.927M
Date Value
March 31, 2020 5.228M
December 31, 2019 5.084M
September 30, 2019 5.413M
June 30, 2019 5.261M
March 31, 2019 5.668M
December 31, 2018 5.654M
September 30, 2018 5.317M
June 30, 2018 5.182M
March 31, 2018 5.396M
December 31, 2017 5.679M
September 30, 2017 6.274M
June 30, 2017 6.484M
March 31, 2017 5.932M
December 31, 2016 5.853M
September 30, 2016 8.818M
June 30, 2016 9.459M
July 31, 2015 9.806M
April 30, 2015 9.887M
January 31, 2015 14.53M
October 31, 2014 14.41M
July 31, 2014 14.24M
April 30, 2014 13.77M
January 31, 2014 4.736M
October 31, 2013 4.394M
July 31, 2013 3.396M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Exicure, Inc. 5.28M
Century Therapeutics, Inc. 20.16M
Absci Corp. 35.28M
Celularity, Inc. 51.27M
Cardio Diagnostics Holdings, Inc. 3.501M